| Aug 16 |
Pfizer, BioNTech post partial win in late-stage trial for COVID/flu combo shot
|
| Aug 16 |
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
|
| Aug 13 |
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
|
| Aug 13 |
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
|
| Aug 13 |
Maravai cut at Morgan Stanley; Pfizer/BioNTech headwinds cited
|
| Aug 8 |
3 Biotech Stocks With Promising Drug Pipelines: August 2024
|
| Aug 7 |
BioNTech Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 7 |
BioNTech sued by University of Pennsylvania over COVID-19 vaccine patent royalties
|
| Aug 6 |
BioNTech Q2 Earnings Review: No Needle-Moving Catalysts Despite Oncology Promise
|
| Aug 5 |
BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript
|
